The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Matiakin E.G.

Rossiĭskiĭ onkologicheskiĭ nauchnyĭ tsentr im. N.N. Blokhina RAMN

Ilkaev K.D.

Otdelenie opukholeĭ cherepno-cheliustno-litsevoĭ oblasti, otdelenie opukholeĭ verkhnikh dykhatel'nykh i pishchevaritel'nykh puteĭ FGBU "Rossiĭskiĭ onkologicheskiĭ nauchnyĭ tsentr im. N.N. Blokhina" RAMN, Moskva

Azizjan R.I.

GBOU VPO «Moskovskij gosudarstvennyj mediko-stomatologicheskij universitet im. A.I. Evdokimova» Minzdrava Rossii;
FGBU «Rossijskij onkologicheskij tsentr im. N.N. Blohina» RAMN, Moskva, Rossijskaja Federatsija

Chuchkov V.M.

Blokhin Russian Cancer Research Center, Moscow, Russia

Anurova O.A.

N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia, Moscow, Russia

Dronova E.L.

Blokhin Russian Cancer Research Center, Moscow, Russia;
Blokhin Russian Cancer Research Center, Moscow, Russia;
Blokhin Russian Cancer Research Center, Moscow, Russia

Gvetadze Sh.R.

Tsentral'nyĭ nauchno-issledovatel'skiĭ institut stomatologii i cheliustno-litsevoĭ khirurgii Minzdrava Rossii;
kafedra khirurgicheskoĭ stomatologii i cheliustno-litsevoĭ khirurgii RMAPO

Fibromyxoid sarcoma of maxilla

Authors:

Matiakin E.G., Ilkaev K.D., Azizjan R.I., Chuchkov V.M., Anurova O.A., Dronova E.L., Gvetadze Sh.R.

More about the authors

Journal: Stomatology. 2017;96(3): 40‑44

Read: 7613 times


To cite this article:

Matiakin EG, Ilkaev KD, Azizjan RI, Chuchkov VM, Anurova OA, Dronova EL, Gvetadze ShR. Fibromyxoid sarcoma of maxilla. Stomatology. 2017;96(3):40‑44. (In Russ.)
https://doi.org/10.17116/stomat201796340-44

Recommended articles:
The problem of chro­nic postoperative pain. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(5-2):102-107
Coexistence of bronchial asthma and myasthenia gravis. (Clinical case). Journal of Respiratory Medi­cine. 2025;(4):53-58

References:

  1. Meis-Kindblom JM, Kindblom LG, Enzinger FM. Sclerosingepithelioidfibrosarcoma. A variant of fibrosarcoma simulating carcinoma. Am J Surg Pathol. 1995;19:979-993.
  2. Antonescu CR, Rosenblum MK, Pereira P et al. Sclerosingepithelioidfibro sarcoma: a study of 16 cases and confirmation of a clinicopathologically distinct tumor. Am J Surg Pathol. 2001;25:699-709.
  3. Bilsky MH, Schefler AC, Sandberg DI, et al. Sclerosingepithe- lioidfibrosarcomas involving the neuraxis: report of three cases. Neurosurgery. 2000;47:956-959; discussion 959-960.
  4. Abdulkader I, Cameselle-Teijeiro J, Fraga M et al. Sclerosingepithelioidfibro sarcoma primary of the bone. Int J Surg Pathol. 2002;10:227-230.
  5. Battiata AP, Casler J. Sclerosingepithelioidfibrosarcoma: a case report. Ann Otol Rhinol Laryngol. 2005;114:87-89.
  6. O’Brien JE, Stout AP. Malignant fibrous xanthomas. Cancer. 1964;17:1445-1455.
  7. Mansoor A, White CRJr. Myxofibrosarcoma presenting in the skin: clinicopathological features and differential diagnosis with cutaneous myxoid neoplasms. Am J Dermatopathol. 2003;25(4):281-286. PubMed PMID: 12876484.
  8. Wada T, Hasegawa T, Nagoya S, Kawaguchi S, Kaya M, Ishii S. Myxofibrosarcoma with an infiltrative growth pattern: a case report. Jpn J Clin Oncol. 2000;30(10):458-462. PubMed PMID: 11185894.
  9. Fletcher CDM, Mehrtens F. World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone. France: IARC Press; 2002.
  10. Mentzel T, Calonje E, Wadden C, Camplejohn RS, Beham A, Smith MA, Fletcher CD. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol. 1996;20(4):391-405. PubMed PMID: 8604805.
  11. Huang HY, Lal P, Qin J, Brennan MF, Antonescu CR. Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems. Hum Pathol. 2004;35(5):612-6621. PubMed PMID: 15138937.
  12. Nishio J, Iwasaki H, Nabeshima K, Naito M. Cytogenetics and molecular genetics of myxoid soft-tissue sarcomas. Genet Res Int. 2011;497148. PubMed PMID: 22567356; PubMed Central PMCID: PMC3335514. doi:10.4061/2011/497148
  13. Sanfilippo R, Miceli R, Grosso F, Fiore M, Puma E, Pennacchioli E, Barisella M, Sangalli C, Mariani L, Casali PG, Gronchi A. Myxofibrosarcoma: prognostic factors and survival in a series of patients treated at a single institution. Ann Surg Oncol. 2011;18(3):720-725. PubMed PMID: 20878245. doi:10.1245/s10434-010-1341-4
  14. Qiubei Z, Cheng L, Yaping X, Shunzhang L, Jingping F: Myxofibrosarcoma of the sinus piriformis: case report and literature review. World J Surg Oncol. 2012;10:245. PubMed PMID: 23152982. PubMed Central PMCID: PMC3534627. doi:10.1186/1477-7819-10-245
  15. Cante D, Franco P, Sciacero P, Girelli GF, Casanova Borca V, Pasquino M, Tofani S, Bombaci S, Migliaccio F, Marra A, Numico G, LaPorta MR, Ricardi U. Combined chemoradiation for head and neck region myxofibrosarcoma of the maxillary sinus. Tumori. 2013;99(2):80-83. doi:10.1700/1283.14214
  16. Huang HY, Lal P, Qin J et al. Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems. Hum Pathol. 2004;35:612-621.
  17. Zagars GK, Mullen JR, Pollack A. Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 1996;34:983-994.
  18. Zagars GK, Ballo MT, Pisters PW et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. 2003;97:2530-2543.
  19. Merck C, Angervall L, Kindblom LG et al. Myxofibrosarcoma.A malignant soft tissue tumor of fibroblastic-histiocytic origin. A clinicopathologic and prognostic study of 110 cases using multivariate analysis. Acta Pathol Microbiol Immunol Scand Suppl. 1983;282:1-40.
  20. deBree R, van der Valk P, Kuik DJ et al. Prognostic factors in adult soft tissue sarcomas of the head and neck: a single-centre experience. Oral Oncol. 2006;42:703-709.
  21. Wang CP, Chang YL, Ting LL et al. Malignant fibrous histiocytoma of the sinonasal tract. Head Neck. 2009;31:85-93.
  22. Kaya M, Wada T, Nagoya S, Sasaki M, Matsumura T, Yamaguchi T et al. MRI and histological evaluation of the infiltrative growth pattern 9 of myxofibrosarcoma. Skeletal Radiol. 2008;37:1085-1090.
  23. Lin CN, Chou SC, Li CF, Tsai KB, Chen WC, Hsiung CY. Prognostic factors of myxofibrosarcomas: Implications of margin status, tumor necrosis, and mitotic rate on survival. J Surg Oncol. 2006;93:294-303.
  24. Sanfilippo R, Miceli R, Grosso F, Fiore M, Puma E, Pennacchioli E et al. Myxofibrosarcoma: Prognostic Factors and Survival in a Series of Patients Treated at a Single Institution. Ann Surg Oncol. 2010.
  25. Waters B, Panicek DM, Lefkowitz RA, Antonescu CA, Healey JA, Athanasian EA et al. Low-Grade Myxofibrosarcoma: CT and MRI Patterns in Recurrent Disease. Am J Roentgenol. 2007;188:193-198.
  26. Wada T, Hasegawa T, Nagoya S, Kawaguchi S, Kaya M, Ishii S. Myxofibrosarcoma with an infiltrativegrowth pattern: A case report. Jpn J Clin Oncol. 2000;30:458-462.
  27. Taghi AS, Ali A, Kuchai R, Saleh H. Rare sarcoma presented as sinusitis. BMJ Cases Rep. 2012. pii: bcr0220125863. doi:10. 1136/bcr-02-2012-5863
  28. Kraevskii N.A., Smol'yannikov A.V. Rukovodstvo po patologoanatomicheskoi diagnostike opukholei cheloveka. M.: Meditsina; 1971.
  29. Harnsberber HR, Wiggins RH, HudginsPA, Michel MA, Swartz J, Davidson HC, Macdonald AJ, Glastonbury CM, Cure JK, Branstetter B. Diagnostic imaging head and neck. Elsevier. 2006.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.